nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2E1—obesity	0.172	1	CbGaD
Carbinoxamine—Doxylamine—Benzphetamine—obesity	0.0555	0.181	CrCrCtD
Carbinoxamine—Tripelennamine—Benzphetamine—obesity	0.0502	0.164	CrCrCtD
Carbinoxamine—Bromodiphenhydramine—Benzphetamine—obesity	0.0469	0.153	CrCrCtD
Carbinoxamine—Pheniramine—Benzphetamine—obesity	0.0459	0.15	CrCrCtD
Carbinoxamine—CYP2B6—Benzphetamine—obesity	0.0389	0.105	CbGbCtD
Carbinoxamine—Clofedanol—Benzphetamine—obesity	0.0381	0.124	CrCrCtD
Carbinoxamine—Orphenadrine—Benzphetamine—obesity	0.0369	0.12	CrCrCtD
Carbinoxamine—CYP2E1—Bupropion—obesity	0.0335	0.0907	CbGbCtD
Carbinoxamine—CYP2B6—Bupropion—obesity	0.0331	0.0894	CbGbCtD
Carbinoxamine—Diphenhydramine—Benzphetamine—obesity	0.0328	0.107	CrCrCtD
Carbinoxamine—CYP2C8—Bupropion—obesity	0.025	0.0677	CbGbCtD
Carbinoxamine—CYP2E1—Cimetidine—obesity	0.0246	0.0665	CbGbCtD
Carbinoxamine—CYP2C9—Phentermine—obesity	0.0205	0.0556	CbGbCtD
Carbinoxamine—CYP2D6—Phentermine—obesity	0.0188	0.0508	CbGbCtD
Carbinoxamine—CYP2C8—Cimetidine—obesity	0.0184	0.0497	CbGbCtD
Carbinoxamine—CYP2C9—Bupropion—obesity	0.0175	0.0472	CbGbCtD
Carbinoxamine—CYP2D6—Bupropion—obesity	0.016	0.0432	CbGbCtD
Carbinoxamine—CYP3A4—Sibutramine—obesity	0.0158	0.0426	CbGbCtD
Carbinoxamine—CYP2C19—Cimetidine—obesity	0.0154	0.0417	CbGbCtD
Carbinoxamine—CYP2D6—Methamphetamine—obesity	0.015	0.0406	CbGbCtD
Carbinoxamine—CYP2C9—Cimetidine—obesity	0.0128	0.0347	CbGbCtD
Carbinoxamine—CYP3A4—Benzphetamine—obesity	0.0119	0.0323	CbGbCtD
Carbinoxamine—CYP2D6—Cimetidine—obesity	0.0117	0.0317	CbGbCtD
Carbinoxamine—CYP3A4—Bupropion—obesity	0.0102	0.0275	CbGbCtD
Carbinoxamine—CYP2C19—Topiramate—obesity	0.0101	0.0273	CbGbCtD
Carbinoxamine—CYP3A4—Orlistat—obesity	0.00828	0.0224	CbGbCtD
Carbinoxamine—CYP3A4—Cimetidine—obesity	0.00746	0.0202	CbGbCtD
Carbinoxamine—CYP3A4—Topiramate—obesity	0.00488	0.0132	CbGbCtD
Carbinoxamine—Agitation—Benzphetamine—obesity	0.000766	0.00781	CcSEcCtD
Carbinoxamine—Palpitations—Methamphetamine—obesity	0.000764	0.00779	CcSEcCtD
Carbinoxamine—Sweating increased—Diethylpropion—obesity	0.000755	0.0077	CcSEcCtD
Carbinoxamine—Palpitations—Benzphetamine—obesity	0.000737	0.00751	CcSEcCtD
Carbinoxamine—Vision blurred—Phendimetrazine—obesity	0.000716	0.0073	CcSEcCtD
Carbinoxamine—Tremor—Phendimetrazine—obesity	0.000712	0.00726	CcSEcCtD
Carbinoxamine—Chest discomfort—Sibutramine—obesity	0.00071	0.00724	CcSEcCtD
Carbinoxamine—Agitation—Phendimetrazine—obesity	0.000698	0.00712	CcSEcCtD
Carbinoxamine—Drowsiness—Diethylpropion—obesity	0.000691	0.00705	CcSEcCtD
Carbinoxamine—Tachycardia—Methamphetamine—obesity	0.000689	0.00702	CcSEcCtD
Carbinoxamine—Palpitations—Phendimetrazine—obesity	0.000671	0.00685	CcSEcCtD
Carbinoxamine—Tachycardia—Benzphetamine—obesity	0.000664	0.00677	CcSEcCtD
Carbinoxamine—Drowsiness—Cimetidine—obesity	0.000658	0.00671	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Benzphetamine—obesity	0.000658	0.00671	CcSEcCtD
Carbinoxamine—Extrasystoles—Bupropion—obesity	0.000651	0.00664	CcSEcCtD
Carbinoxamine—Anorexia—Benzphetamine—obesity	0.000648	0.00661	CcSEcCtD
Carbinoxamine—Agranulocytosis—Diethylpropion—obesity	0.000645	0.00658	CcSEcCtD
Carbinoxamine—Insomnia—Methamphetamine—obesity	0.000638	0.00651	CcSEcCtD
Carbinoxamine—Tension—Phenylpropanolamine—obesity	0.000637	0.00649	CcSEcCtD
Carbinoxamine—Nervousness—Phenylpropanolamine—obesity	0.00063	0.00643	CcSEcCtD
Carbinoxamine—Dyspepsia—Methamphetamine—obesity	0.000621	0.00633	CcSEcCtD
Carbinoxamine—Chest discomfort—Bupropion—obesity	0.000619	0.00631	CcSEcCtD
Carbinoxamine—Insomnia—Benzphetamine—obesity	0.000615	0.00627	CcSEcCtD
Carbinoxamine—Agranulocytosis—Cimetidine—obesity	0.000614	0.00626	CcSEcCtD
Carbinoxamine—Vision blurred—Phenylpropanolamine—obesity	0.000612	0.00624	CcSEcCtD
Carbinoxamine—Tension—Phentermine—obesity	0.000609	0.00622	CcSEcCtD
Carbinoxamine—Tremor—Phenylpropanolamine—obesity	0.000608	0.0062	CcSEcCtD
Carbinoxamine—Tachycardia—Phendimetrazine—obesity	0.000605	0.00617	CcSEcCtD
Carbinoxamine—Constipation—Methamphetamine—obesity	0.000603	0.00615	CcSEcCtD
Carbinoxamine—Nervousness—Phentermine—obesity	0.000603	0.00615	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Phendimetrazine—obesity	0.000599	0.00611	CcSEcCtD
Carbinoxamine—Dyspepsia—Benzphetamine—obesity	0.000599	0.00611	CcSEcCtD
Carbinoxamine—Agitation—Phenylpropanolamine—obesity	0.000596	0.00608	CcSEcCtD
Carbinoxamine—Decreased appetite—Benzphetamine—obesity	0.000591	0.00603	CcSEcCtD
Carbinoxamine—Anorexia—Phendimetrazine—obesity	0.000591	0.00603	CcSEcCtD
Carbinoxamine—Tremor—Phentermine—obesity	0.000582	0.00593	CcSEcCtD
Carbinoxamine—Agitation—Phentermine—obesity	0.000571	0.00582	CcSEcCtD
Carbinoxamine—Insomnia—Phendimetrazine—obesity	0.000561	0.00572	CcSEcCtD
Carbinoxamine—Urticaria—Methamphetamine—obesity	0.00056	0.00572	CcSEcCtD
Carbinoxamine—Palpitations—Phentermine—obesity	0.000549	0.0056	CcSEcCtD
Carbinoxamine—Urticaria—Benzphetamine—obesity	0.00054	0.00551	CcSEcCtD
Carbinoxamine—Euphoric mood—Sibutramine—obesity	0.00054	0.00551	CcSEcCtD
Carbinoxamine—Decreased appetite—Phendimetrazine—obesity	0.000539	0.0055	CcSEcCtD
Carbinoxamine—Confusional state—Phenylpropanolamine—obesity	0.000534	0.00545	CcSEcCtD
Carbinoxamine—Wheezing—Bupropion—obesity	0.000532	0.00543	CcSEcCtD
Carbinoxamine—Constipation—Phendimetrazine—obesity	0.00053	0.00541	CcSEcCtD
Carbinoxamine—Tension—Diethylpropion—obesity	0.00053	0.00541	CcSEcCtD
Carbinoxamine—Nervousness—Diethylpropion—obesity	0.000525	0.00535	CcSEcCtD
Carbinoxamine—Photosensitivity—Sibutramine—obesity	0.000519	0.0053	CcSEcCtD
Carbinoxamine—Tachycardia—Phenylpropanolamine—obesity	0.000517	0.00527	CcSEcCtD
Carbinoxamine—Vision blurred—Diethylpropion—obesity	0.000509	0.00519	CcSEcCtD
Carbinoxamine—Tremor—Diethylpropion—obesity	0.000506	0.00516	CcSEcCtD
Carbinoxamine—Nasal congestion—Sibutramine—obesity	0.000501	0.00511	CcSEcCtD
Carbinoxamine—Agitation—Diethylpropion—obesity	0.000497	0.00506	CcSEcCtD
Carbinoxamine—Hypotension—Phenylpropanolamine—obesity	0.000495	0.00505	CcSEcCtD
Carbinoxamine—Tachycardia—Phentermine—obesity	0.000495	0.00504	CcSEcCtD
Carbinoxamine—Diarrhoea—Methamphetamine—obesity	0.000483	0.00492	CcSEcCtD
Carbinoxamine—Insomnia—Phenylpropanolamine—obesity	0.000479	0.00489	CcSEcCtD
Carbinoxamine—Palpitations—Diethylpropion—obesity	0.000477	0.00487	CcSEcCtD
Carbinoxamine—Agitation—Cimetidine—obesity	0.000472	0.00482	CcSEcCtD
Carbinoxamine—Somnolence—Phenylpropanolamine—obesity	0.000471	0.0048	CcSEcCtD
Carbinoxamine—Euphoric mood—Bupropion—obesity	0.000471	0.0048	CcSEcCtD
Carbinoxamine—Convulsion—Diethylpropion—obesity	0.000468	0.00477	CcSEcCtD
Carbinoxamine—Dizziness—Methamphetamine—obesity	0.000467	0.00476	CcSEcCtD
Carbinoxamine—Diarrhoea—Benzphetamine—obesity	0.000465	0.00475	CcSEcCtD
Carbinoxamine—Insomnia—Phentermine—obesity	0.000458	0.00468	CcSEcCtD
Carbinoxamine—Constipation—Phenylpropanolamine—obesity	0.000453	0.00462	CcSEcCtD
Carbinoxamine—Photosensitivity—Bupropion—obesity	0.000453	0.00462	CcSEcCtD
Carbinoxamine—Dizziness—Benzphetamine—obesity	0.00045	0.00459	CcSEcCtD
Carbinoxamine—Dyspepsia—Phentermine—obesity	0.000446	0.00455	CcSEcCtD
Carbinoxamine—Headache—Methamphetamine—obesity	0.000442	0.00451	CcSEcCtD
Carbinoxamine—Fatigue—Phentermine—obesity	0.000437	0.00446	CcSEcCtD
Carbinoxamine—Nasal congestion—Bupropion—obesity	0.000436	0.00445	CcSEcCtD
Carbinoxamine—Feeling abnormal—Phenylpropanolamine—obesity	0.000436	0.00445	CcSEcCtD
Carbinoxamine—Urinary retention—Sibutramine—obesity	0.000434	0.00442	CcSEcCtD
Carbinoxamine—Constipation—Phentermine—obesity	0.000433	0.00442	CcSEcCtD
Carbinoxamine—Tachycardia—Diethylpropion—obesity	0.00043	0.00439	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Diethylpropion—obesity	0.000426	0.00435	CcSEcCtD
Carbinoxamine—Headache—Benzphetamine—obesity	0.000426	0.00435	CcSEcCtD
Carbinoxamine—Diarrhoea—Phendimetrazine—obesity	0.000424	0.00433	CcSEcCtD
Carbinoxamine—Confusional state—Cimetidine—obesity	0.000423	0.00431	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Cimetidine—obesity	0.000411	0.00419	CcSEcCtD
Carbinoxamine—Dizziness—Phendimetrazine—obesity	0.00041	0.00418	CcSEcCtD
Carbinoxamine—Tachycardia—Cimetidine—obesity	0.000409	0.00418	CcSEcCtD
Carbinoxamine—Nausea—Benzphetamine—obesity	0.000404	0.00412	CcSEcCtD
Carbinoxamine—Urticaria—Phentermine—obesity	0.000403	0.00411	CcSEcCtD
Carbinoxamine—Insomnia—Diethylpropion—obesity	0.000399	0.00407	CcSEcCtD
Carbinoxamine—Diplopia—Bupropion—obesity	0.000398	0.00406	CcSEcCtD
Carbinoxamine—Sweating increased—Orlistat—obesity	0.000397	0.00405	CcSEcCtD
Carbinoxamine—Somnolence—Diethylpropion—obesity	0.000392	0.004	CcSEcCtD
Carbinoxamine—Headache—Phendimetrazine—obesity	0.000388	0.00396	CcSEcCtD
Carbinoxamine—Dyspepsia—Diethylpropion—obesity	0.000388	0.00396	CcSEcCtD
Carbinoxamine—Irritability—Bupropion—obesity	0.00038	0.00387	CcSEcCtD
Carbinoxamine—Urinary retention—Bupropion—obesity	0.000378	0.00386	CcSEcCtD
Carbinoxamine—Constipation—Diethylpropion—obesity	0.000377	0.00385	CcSEcCtD
Carbinoxamine—Somnolence—Cimetidine—obesity	0.000373	0.0038	CcSEcCtD
Carbinoxamine—Nausea—Phendimetrazine—obesity	0.000368	0.00376	CcSEcCtD
Carbinoxamine—Pollakiuria—Sibutramine—obesity	0.000364	0.00371	CcSEcCtD
Carbinoxamine—Asthenia—Phentermine—obesity	0.000364	0.00371	CcSEcCtD
Carbinoxamine—Feeling abnormal—Diethylpropion—obesity	0.000363	0.00371	CcSEcCtD
Carbinoxamine—Fatigue—Cimetidine—obesity	0.000362	0.00369	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Sibutramine—obesity	0.00036	0.00367	CcSEcCtD
Carbinoxamine—Constipation—Cimetidine—obesity	0.000359	0.00366	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Orlistat—obesity	0.000356	0.00363	CcSEcCtD
Carbinoxamine—Urticaria—Diethylpropion—obesity	0.00035	0.00357	CcSEcCtD
Carbinoxamine—Dizziness—Phenylpropanolamine—obesity	0.00035	0.00357	CcSEcCtD
Carbinoxamine—Diarrhoea—Phentermine—obesity	0.000347	0.00354	CcSEcCtD
Carbinoxamine—Feeling abnormal—Cimetidine—obesity	0.000346	0.00353	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Sibutramine—obesity	0.000345	0.00351	CcSEcCtD
Carbinoxamine—Mitotane—SHBG—obesity	0.000342	0.16	CrCbGaD
Carbinoxamine—Vomiting—Phenylpropanolamine—obesity	0.000337	0.00343	CcSEcCtD
Carbinoxamine—Dizziness—Phentermine—obesity	0.000335	0.00342	CcSEcCtD
Carbinoxamine—Sweating increased—Bupropion—obesity	0.000335	0.00341	CcSEcCtD
Carbinoxamine—Vomiting—Phentermine—obesity	0.000322	0.00329	CcSEcCtD
Carbinoxamine—Headache—Phentermine—obesity	0.000318	0.00324	CcSEcCtD
Carbinoxamine—Pollakiuria—Bupropion—obesity	0.000317	0.00324	CcSEcCtD
Carbinoxamine—Nausea—Phenylpropanolamine—obesity	0.000315	0.00321	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Bupropion—obesity	0.000314	0.0032	CcSEcCtD
Carbinoxamine—Diarrhoea—Diethylpropion—obesity	0.000302	0.00308	CcSEcCtD
Carbinoxamine—Nausea—Phentermine—obesity	0.000301	0.00307	CcSEcCtD
Carbinoxamine—Asthenia—Cimetidine—obesity	0.000301	0.00307	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Bupropion—obesity	0.0003	0.00306	CcSEcCtD
Carbinoxamine—Euphoric mood—Topiramate—obesity	0.0003	0.00306	CcSEcCtD
Carbinoxamine—Tinnitus—Sibutramine—obesity	0.000294	0.003	CcSEcCtD
Carbinoxamine—Dizziness—Diethylpropion—obesity	0.000292	0.00297	CcSEcCtD
Carbinoxamine—Diarrhoea—Cimetidine—obesity	0.000287	0.00293	CcSEcCtD
Carbinoxamine—Chills—Sibutramine—obesity	0.000283	0.00289	CcSEcCtD
Carbinoxamine—Vomiting—Diethylpropion—obesity	0.00028	0.00286	CcSEcCtD
Carbinoxamine—Nasal congestion—Topiramate—obesity	0.000278	0.00284	CcSEcCtD
Carbinoxamine—Dizziness—Cimetidine—obesity	0.000277	0.00283	CcSEcCtD
Carbinoxamine—Headache—Diethylpropion—obesity	0.000276	0.00282	CcSEcCtD
Carbinoxamine—Tension—Sibutramine—obesity	0.00027	0.00275	CcSEcCtD
Carbinoxamine—Vision blurred—Orlistat—obesity	0.000267	0.00273	CcSEcCtD
Carbinoxamine—Nervousness—Sibutramine—obesity	0.000267	0.00272	CcSEcCtD
Carbinoxamine—Vomiting—Cimetidine—obesity	0.000267	0.00272	CcSEcCtD
Carbinoxamine—Headache—Cimetidine—obesity	0.000263	0.00268	CcSEcCtD
Carbinoxamine—Nausea—Diethylpropion—obesity	0.000262	0.00267	CcSEcCtD
Carbinoxamine—Vision blurred—Sibutramine—obesity	0.000259	0.00264	CcSEcCtD
Carbinoxamine—Tremor—Sibutramine—obesity	0.000257	0.00262	CcSEcCtD
Carbinoxamine—Tinnitus—Bupropion—obesity	0.000256	0.00262	CcSEcCtD
Carbinoxamine—Vertigo—Orlistat—obesity	0.000255	0.0026	CcSEcCtD
Carbinoxamine—Diplopia—Topiramate—obesity	0.000253	0.00258	CcSEcCtD
Carbinoxamine—Agitation—Sibutramine—obesity	0.000252	0.00257	CcSEcCtD
Carbinoxamine—Palpitations—Orlistat—obesity	0.000251	0.00256	CcSEcCtD
Carbinoxamine—Nausea—Cimetidine—obesity	0.000249	0.00254	CcSEcCtD
Carbinoxamine—Chills—Bupropion—obesity	0.000247	0.00252	CcSEcCtD
Carbinoxamine—Vertigo—Sibutramine—obesity	0.000247	0.00252	CcSEcCtD
Carbinoxamine—Captodiame—HTR2C—obesity	0.000246	0.115	CrCbGaD
Carbinoxamine—Convulsion—Orlistat—obesity	0.000246	0.00251	CcSEcCtD
Carbinoxamine—Palpitations—Sibutramine—obesity	0.000243	0.00248	CcSEcCtD
Carbinoxamine—Irritability—Topiramate—obesity	0.000242	0.00247	CcSEcCtD
Carbinoxamine—Urinary retention—Topiramate—obesity	0.000241	0.00246	CcSEcCtD
Carbinoxamine—Convulsion—Sibutramine—obesity	0.000238	0.00243	CcSEcCtD
Carbinoxamine—Tension—Bupropion—obesity	0.000235	0.0024	CcSEcCtD
Carbinoxamine—Nervousness—Bupropion—obesity	0.000233	0.00237	CcSEcCtD
Carbinoxamine—Confusional state—Sibutramine—obesity	0.000226	0.00231	CcSEcCtD
Carbinoxamine—Vision blurred—Bupropion—obesity	0.000226	0.0023	CcSEcCtD
Carbinoxamine—Tremor—Bupropion—obesity	0.000224	0.00229	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Orlistat—obesity	0.000224	0.00228	CcSEcCtD
Carbinoxamine—Agitation—Bupropion—obesity	0.00022	0.00224	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Sibutramine—obesity	0.000219	0.00224	CcSEcCtD
Carbinoxamine—Tachycardia—Sibutramine—obesity	0.000219	0.00223	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Sibutramine—obesity	0.000217	0.00221	CcSEcCtD
Carbinoxamine—Vertigo—Bupropion—obesity	0.000215	0.00219	CcSEcCtD
Carbinoxamine—Anorexia—Sibutramine—obesity	0.000214	0.00218	CcSEcCtD
Carbinoxamine—Sweating increased—Topiramate—obesity	0.000213	0.00218	CcSEcCtD
Carbinoxamine—Palpitations—Bupropion—obesity	0.000212	0.00216	CcSEcCtD
Carbinoxamine—Insomnia—Orlistat—obesity	0.000209	0.00214	CcSEcCtD
Carbinoxamine—Hypotension—Sibutramine—obesity	0.000209	0.00214	CcSEcCtD
Carbinoxamine—Paraesthesia—Orlistat—obesity	0.000208	0.00212	CcSEcCtD
Carbinoxamine—Convulsion—Bupropion—obesity	0.000207	0.00212	CcSEcCtD
Carbinoxamine—Dyspepsia—Orlistat—obesity	0.000204	0.00208	CcSEcCtD
Carbinoxamine—Insomnia—Sibutramine—obesity	0.000203	0.00207	CcSEcCtD
Carbinoxamine—Pollakiuria—Topiramate—obesity	0.000202	0.00206	CcSEcCtD
Carbinoxamine—Decreased appetite—Orlistat—obesity	0.000201	0.00205	CcSEcCtD
Carbinoxamine—Paraesthesia—Sibutramine—obesity	0.000201	0.00205	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Topiramate—obesity	0.0002	0.00204	CcSEcCtD
Carbinoxamine—Fatigue—Orlistat—obesity	0.0002	0.00204	CcSEcCtD
Carbinoxamine—Somnolence—Sibutramine—obesity	0.000199	0.00203	CcSEcCtD
Carbinoxamine—Dyspepsia—Sibutramine—obesity	0.000197	0.00201	CcSEcCtD
Carbinoxamine—Confusional state—Bupropion—obesity	0.000197	0.00201	CcSEcCtD
Carbinoxamine—Decreased appetite—Sibutramine—obesity	0.000195	0.00199	CcSEcCtD
Carbinoxamine—Constipation—Sibutramine—obesity	0.000192	0.00195	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Topiramate—obesity	0.000191	0.00195	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Bupropion—obesity	0.000191	0.00195	CcSEcCtD
Carbinoxamine—Feeling abnormal—Orlistat—obesity	0.000191	0.00195	CcSEcCtD
Carbinoxamine—Tachycardia—Bupropion—obesity	0.000191	0.00195	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Bupropion—obesity	0.000189	0.00193	CcSEcCtD
Carbinoxamine—Anorexia—Bupropion—obesity	0.000186	0.0019	CcSEcCtD
Carbinoxamine—Feeling abnormal—Sibutramine—obesity	0.000185	0.00188	CcSEcCtD
Carbinoxamine—Urticaria—Orlistat—obesity	0.000184	0.00188	CcSEcCtD
Carbinoxamine—Hypotension—Bupropion—obesity	0.000183	0.00186	CcSEcCtD
Carbinoxamine—Agranulocytosis—Topiramate—obesity	0.000182	0.00186	CcSEcCtD
Carbinoxamine—Urticaria—Sibutramine—obesity	0.000178	0.00182	CcSEcCtD
Carbinoxamine—Insomnia—Bupropion—obesity	0.000177	0.0018	CcSEcCtD
Carbinoxamine—Paraesthesia—Bupropion—obesity	0.000175	0.00179	CcSEcCtD
Carbinoxamine—Somnolence—Bupropion—obesity	0.000174	0.00177	CcSEcCtD
Carbinoxamine—Dyspepsia—Bupropion—obesity	0.000172	0.00175	CcSEcCtD
Carbinoxamine—Decreased appetite—Bupropion—obesity	0.00017	0.00173	CcSEcCtD
Carbinoxamine—Fatigue—Bupropion—obesity	0.000168	0.00172	CcSEcCtD
Carbinoxamine—Constipation—Bupropion—obesity	0.000167	0.0017	CcSEcCtD
Carbinoxamine—Asthenia—Orlistat—obesity	0.000166	0.00169	CcSEcCtD
Carbinoxamine—Tinnitus—Topiramate—obesity	0.000163	0.00167	CcSEcCtD
Carbinoxamine—Feeling abnormal—Bupropion—obesity	0.000161	0.00164	CcSEcCtD
Carbinoxamine—Asthenia—Sibutramine—obesity	0.000161	0.00164	CcSEcCtD
Carbinoxamine—Chlorphenamine—SLC22A1—obesity	0.000159	0.0743	CrCbGaD
Carbinoxamine—Diarrhoea—Orlistat—obesity	0.000158	0.00162	CcSEcCtD
Carbinoxamine—Chills—Topiramate—obesity	0.000157	0.0016	CcSEcCtD
Carbinoxamine—Urticaria—Bupropion—obesity	0.000155	0.00158	CcSEcCtD
Carbinoxamine—Diarrhoea—Sibutramine—obesity	0.000153	0.00156	CcSEcCtD
Carbinoxamine—Dizziness—Orlistat—obesity	0.000153	0.00156	CcSEcCtD
Carbinoxamine—Tension—Topiramate—obesity	0.00015	0.00153	CcSEcCtD
Carbinoxamine—Dizziness—Sibutramine—obesity	0.000148	0.00151	CcSEcCtD
Carbinoxamine—Nervousness—Topiramate—obesity	0.000148	0.00151	CcSEcCtD
Carbinoxamine—Vomiting—Orlistat—obesity	0.000147	0.0015	CcSEcCtD
Carbinoxamine—Headache—Orlistat—obesity	0.000145	0.00148	CcSEcCtD
Carbinoxamine—Vision blurred—Topiramate—obesity	0.000144	0.00147	CcSEcCtD
Carbinoxamine—Tremor—Topiramate—obesity	0.000143	0.00146	CcSEcCtD
Carbinoxamine—Vomiting—Sibutramine—obesity	0.000143	0.00145	CcSEcCtD
Carbinoxamine—Headache—Sibutramine—obesity	0.00014	0.00143	CcSEcCtD
Carbinoxamine—Asthenia—Bupropion—obesity	0.00014	0.00143	CcSEcCtD
Carbinoxamine—Agitation—Topiramate—obesity	0.00014	0.00143	CcSEcCtD
Carbinoxamine—Nausea—Orlistat—obesity	0.000138	0.0014	CcSEcCtD
Carbinoxamine—Vertigo—Topiramate—obesity	0.000137	0.0014	CcSEcCtD
Carbinoxamine—Palpitations—Topiramate—obesity	0.000135	0.00137	CcSEcCtD
Carbinoxamine—Diarrhoea—Bupropion—obesity	0.000134	0.00136	CcSEcCtD
Carbinoxamine—Nausea—Sibutramine—obesity	0.000133	0.00136	CcSEcCtD
Carbinoxamine—Convulsion—Topiramate—obesity	0.000132	0.00135	CcSEcCtD
Carbinoxamine—Dizziness—Bupropion—obesity	0.000129	0.00132	CcSEcCtD
Carbinoxamine—Confusional state—Topiramate—obesity	0.000126	0.00128	CcSEcCtD
Carbinoxamine—Vomiting—Bupropion—obesity	0.000124	0.00127	CcSEcCtD
Carbinoxamine—Headache—Bupropion—obesity	0.000122	0.00125	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Topiramate—obesity	0.000122	0.00124	CcSEcCtD
Carbinoxamine—Tachycardia—Topiramate—obesity	0.000122	0.00124	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Topiramate—obesity	0.00012	0.00123	CcSEcCtD
Carbinoxamine—Anorexia—Topiramate—obesity	0.000119	0.00121	CcSEcCtD
Carbinoxamine—Hypotension—Topiramate—obesity	0.000116	0.00119	CcSEcCtD
Carbinoxamine—Nausea—Bupropion—obesity	0.000116	0.00118	CcSEcCtD
Carbinoxamine—Insomnia—Topiramate—obesity	0.000113	0.00115	CcSEcCtD
Carbinoxamine—Paraesthesia—Topiramate—obesity	0.000112	0.00114	CcSEcCtD
Carbinoxamine—Somnolence—Topiramate—obesity	0.000111	0.00113	CcSEcCtD
Carbinoxamine—Dyspepsia—Topiramate—obesity	0.00011	0.00112	CcSEcCtD
Carbinoxamine—Decreased appetite—Topiramate—obesity	0.000108	0.0011	CcSEcCtD
Carbinoxamine—Diphenhydramine—SLC22A1—obesity	0.000108	0.0504	CrCbGaD
Carbinoxamine—Fatigue—Topiramate—obesity	0.000107	0.00109	CcSEcCtD
Carbinoxamine—Constipation—Topiramate—obesity	0.000106	0.00109	CcSEcCtD
Carbinoxamine—Feeling abnormal—Topiramate—obesity	0.000103	0.00105	CcSEcCtD
Carbinoxamine—Urticaria—Topiramate—obesity	9.89e-05	0.00101	CcSEcCtD
Carbinoxamine—Chlorprothixene—DRD1—obesity	9.69e-05	0.0454	CrCbGaD
Carbinoxamine—Chlorphenamine—SLC6A4—obesity	9.18e-05	0.0431	CrCbGaD
Carbinoxamine—Brompheniramine—CYP2E1—obesity	8.96e-05	0.042	CrCbGaD
Carbinoxamine—Asthenia—Topiramate—obesity	8.93e-05	0.000911	CcSEcCtD
Carbinoxamine—Diarrhoea—Topiramate—obesity	8.52e-05	0.000869	CcSEcCtD
Carbinoxamine—Clomipramine—HTR2C—obesity	8.33e-05	0.039	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR2C—obesity	8.29e-05	0.0389	CrCbGaD
Carbinoxamine—Dizziness—Topiramate—obesity	8.23e-05	0.00084	CcSEcCtD
Carbinoxamine—Chlorpromazine—SLC22A1—obesity	8.17e-05	0.0383	CrCbGaD
Carbinoxamine—Vomiting—Topiramate—obesity	7.92e-05	0.000807	CcSEcCtD
Carbinoxamine—Chlorpromazine—DRD4—obesity	7.89e-05	0.037	CrCbGaD
Carbinoxamine—Headache—Topiramate—obesity	7.8e-05	0.000795	CcSEcCtD
Carbinoxamine—Nausea—Topiramate—obesity	7.4e-05	0.000754	CcSEcCtD
Carbinoxamine—Clomipramine—SLC6A4—obesity	6.9e-05	0.0323	CrCbGaD
Carbinoxamine—Chlorprothixene—DRD2—obesity	6.83e-05	0.032	CrCbGaD
Carbinoxamine—Chlorpromazine—DRD1—obesity	6.67e-05	0.0313	CrCbGaD
Carbinoxamine—Chlorpromazine—BCHE—obesity	6.06e-05	0.0284	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR2C—obesity	5.71e-05	0.0268	CrCbGaD
Carbinoxamine—Orphenadrine—CYP2E1—obesity	5.64e-05	0.0265	CrCbGaD
Carbinoxamine—Clomipramine—HTR2A—obesity	5.3e-05	0.0249	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR2A—obesity	5.28e-05	0.0247	CrCbGaD
Carbinoxamine—Chlorpromazine—DRD2—obesity	4.71e-05	0.0221	CrCbGaD
Carbinoxamine—Chlorpromazine—CYP2E1—obesity	4.53e-05	0.0212	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR2A—obesity	3.64e-05	0.017	CrCbGaD
Carbinoxamine—Clomipramine—ALB—obesity	3.63e-05	0.017	CrCbGaD
Carbinoxamine—Chlorpromazine—ALB—obesity	2.49e-05	0.0117	CrCbGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR2A—obesity	3.61e-06	7.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—obesity	3.61e-06	7.04e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—C3—obesity	3.61e-06	7.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A4—obesity	3.6e-06	7e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GCG—obesity	3.6e-06	7e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYCS—obesity	3.58e-06	6.97e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYCS—obesity	3.55e-06	6.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARA—obesity	3.54e-06	6.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GOT1—obesity	3.51e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GGT1—obesity	3.51e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC22A1—obesity	3.51e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CLOCK—obesity	3.51e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AGT—obesity	3.5e-06	6.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GGT1—obesity	3.48e-06	6.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GOT1—obesity	3.48e-06	6.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LPL—obesity	3.47e-06	6.75e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NCOA1—obesity	3.46e-06	6.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—COMT—obesity	3.45e-06	6.71e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOE—obesity	3.43e-06	6.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AGT—obesity	3.43e-06	6.68e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS2—obesity	3.43e-06	6.68e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NCOA1—obesity	3.43e-06	6.68e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGT—obesity	3.43e-06	6.68e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SULT2A1—obesity	3.42e-06	6.66e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GLP1R—obesity	3.42e-06	6.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—STK11—obesity	3.41e-06	6.64e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP19A1—obesity	3.41e-06	6.64e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CAV1—obesity	3.4e-06	6.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARGC1A—obesity	3.4e-06	6.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GNB3—obesity	3.4e-06	6.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOA1—obesity	3.39e-06	6.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—obesity	3.38e-06	6.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—obesity	3.38e-06	6.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—STK11—obesity	3.38e-06	6.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP19A1—obesity	3.38e-06	6.59e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—DPYD—obesity	3.37e-06	6.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOE—obesity	3.36e-06	6.55e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOE—obesity	3.36e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—obesity	3.36e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CAV1—obesity	3.33e-06	6.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CAV1—obesity	3.33e-06	6.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOA1—obesity	3.32e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOA1—obesity	3.32e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GNAS—obesity	3.31e-06	6.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CD36—obesity	3.3e-06	6.42e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOB—obesity	3.24e-06	6.31e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PRKAR2B—obesity	3.24e-06	6.31e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—DCN—obesity	3.22e-06	6.27e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—obesity	3.21e-06	6.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—COMT—obesity	3.17e-06	6.18e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—F2—obesity	3.17e-06	6.17e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCB—obesity	3.17e-06	6.17e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—COMT—obesity	3.14e-06	6.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CPT1A—obesity	3.13e-06	6.1e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BAD—obesity	3.13e-06	6.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GNB3—obesity	3.13e-06	6.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARGC1A—obesity	3.13e-06	6.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—obesity	3.12e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—obesity	3.11e-06	6.06e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GNB3—obesity	3.1e-06	6.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARGC1A—obesity	3.1e-06	6.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CG—obesity	3.1e-06	6.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LPL—obesity	3.1e-06	6.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—obesity	3.09e-06	6.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NAMPT—obesity	3.07e-06	5.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARA—obesity	3.06e-06	5.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LIPC—obesity	3.05e-06	5.94e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCK—obesity	3.05e-06	5.94e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GNAS—obesity	3.05e-06	5.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CG—obesity	3.04e-06	5.91e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOC3—obesity	3.03e-06	5.9e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CG—obesity	3.03e-06	5.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—obesity	3.02e-06	5.88e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GNAS—obesity	3.02e-06	5.88e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS1—obesity	3e-06	5.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—obesity	2.99e-06	5.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOB—obesity	2.98e-06	5.81e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AGT—obesity	2.97e-06	5.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOB—obesity	2.96e-06	5.76e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—POMC—obesity	2.95e-06	5.74e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CETP—obesity	2.94e-06	5.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD36—obesity	2.94e-06	5.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—INS—obesity	2.93e-06	5.71e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—obesity	2.93e-06	5.7e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SDC1—obesity	2.91e-06	5.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOE—obesity	2.91e-06	5.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—POMC—obesity	2.89e-06	5.63e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—POMC—obesity	2.89e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAV1—obesity	2.88e-06	5.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOA1—obesity	2.87e-06	5.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—INS—obesity	2.87e-06	5.6e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—INS—obesity	2.87e-06	5.59e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKR1C3—obesity	2.86e-06	5.58e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LPL—obesity	2.85e-06	5.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—obesity	2.82e-06	5.5e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LPL—obesity	2.82e-06	5.5e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SCARB1—obesity	2.82e-06	5.49e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—obesity	2.79e-06	5.43e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—obesity	2.78e-06	5.41e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—obesity	2.78e-06	5.41e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT2—obesity	2.77e-06	5.4e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—obesity	2.75e-06	5.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.75e-06	5.36e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SREBF1—obesity	2.74e-06	5.33e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARA—obesity	2.73e-06	5.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CD—obesity	2.72e-06	5.31e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD36—obesity	2.71e-06	5.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—obesity	2.69e-06	5.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD36—obesity	2.68e-06	5.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CD—obesity	2.67e-06	5.2e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CD—obesity	2.67e-06	5.19e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GOT2—obesity	2.66e-06	5.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AGT—obesity	2.65e-06	5.16e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—obesity	2.64e-06	5.14e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—obesity	2.64e-06	5.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—obesity	2.63e-06	5.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CG—obesity	2.62e-06	5.11e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FASN—obesity	2.6e-06	5.07e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOE—obesity	2.59e-06	5.05e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BCHE—obesity	2.59e-06	5.05e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3R1—obesity	2.57e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—obesity	2.57e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAV1—obesity	2.57e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOA1—obesity	2.57e-06	5e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TYK2—obesity	2.56e-06	4.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—obesity	2.56e-06	4.99e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RHOA—obesity	2.54e-06	4.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—obesity	2.54e-06	4.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—obesity	2.53e-06	4.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3R1—obesity	2.52e-06	4.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—obesity	2.52e-06	4.91e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3R1—obesity	2.52e-06	4.9e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—obesity	2.52e-06	4.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARA—obesity	2.52e-06	4.9e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2E1—obesity	2.5e-06	4.87e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—POMC—obesity	2.5e-06	4.86e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARA—obesity	2.49e-06	4.86e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—INS—obesity	2.48e-06	4.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NQO1—obesity	2.47e-06	4.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.46e-06	4.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AGT—obesity	2.44e-06	4.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AGT—obesity	2.41e-06	4.7e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—obesity	2.4e-06	4.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOE—obesity	2.39e-06	4.65e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CB—obesity	2.37e-06	4.62e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCG—obesity	2.37e-06	4.62e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A4—obesity	2.37e-06	4.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOE—obesity	2.37e-06	4.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAV1—obesity	2.36e-06	4.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOA1—obesity	2.36e-06	4.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—obesity	2.35e-06	4.58e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAV1—obesity	2.34e-06	4.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CG—obesity	2.34e-06	4.56e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYCS—obesity	2.34e-06	4.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOA1—obesity	2.34e-06	4.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CB—obesity	2.33e-06	4.53e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CB—obesity	2.32e-06	4.52e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MTOR—obesity	2.32e-06	4.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CD—obesity	2.31e-06	4.49e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—obesity	2.3e-06	4.49e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GOT1—obesity	2.3e-06	4.47e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GGT1—obesity	2.3e-06	4.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—obesity	2.28e-06	4.43e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOA1—obesity	2.26e-06	4.41e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—obesity	2.26e-06	4.4e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.24e-06	4.36e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP19A1—obesity	2.23e-06	4.34e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—STK11—obesity	2.23e-06	4.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—POMC—obesity	2.23e-06	4.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—INS—obesity	2.22e-06	4.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—obesity	2.18e-06	4.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3R1—obesity	2.18e-06	4.24e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—obesity	2.16e-06	4.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CG—obesity	2.15e-06	4.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CG—obesity	2.14e-06	4.16e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—obesity	2.12e-06	4.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—obesity	2.08e-06	4.05e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—COMT—obesity	2.07e-06	4.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—obesity	2.06e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CD—obesity	2.06e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—POMC—obesity	2.05e-06	3.99e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GNB3—obesity	2.04e-06	3.98e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARGC1A—obesity	2.04e-06	3.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—INS—obesity	2.04e-06	3.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—obesity	2.04e-06	3.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—POMC—obesity	2.03e-06	3.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—obesity	2.03e-06	3.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—INS—obesity	2.02e-06	3.94e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—obesity	2.02e-06	3.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CB—obesity	2.01e-06	3.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—obesity	1.99e-06	3.88e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GNAS—obesity	1.99e-06	3.88e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK8—obesity	1.96e-06	3.82e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—obesity	1.96e-06	3.81e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOB—obesity	1.95e-06	3.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3R1—obesity	1.94e-06	3.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—obesity	1.94e-06	3.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CD—obesity	1.89e-06	3.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CD—obesity	1.88e-06	3.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—obesity	1.87e-06	3.64e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPL—obesity	1.86e-06	3.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—obesity	1.85e-06	3.61e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—obesity	1.82e-06	3.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—obesity	1.8e-06	3.5e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CB—obesity	1.79e-06	3.49e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—obesity	1.79e-06	3.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3R1—obesity	1.79e-06	3.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—obesity	1.78e-06	3.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3R1—obesity	1.77e-06	3.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—obesity	1.77e-06	3.45e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD36—obesity	1.77e-06	3.44e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—obesity	1.68e-06	3.26e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—obesity	1.67e-06	3.25e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—obesity	1.66e-06	3.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CB—obesity	1.65e-06	3.21e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARA—obesity	1.64e-06	3.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CB—obesity	1.64e-06	3.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—obesity	1.64e-06	3.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—obesity	1.62e-06	3.16e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AGT—obesity	1.59e-06	3.1e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOE—obesity	1.56e-06	3.04e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAV1—obesity	1.55e-06	3.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA1—obesity	1.54e-06	3e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—obesity	1.45e-06	2.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—obesity	1.42e-06	2.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—obesity	1.42e-06	2.76e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CG—obesity	1.41e-06	2.74e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—obesity	1.36e-06	2.65e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—POMC—obesity	1.34e-06	2.61e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—INS—obesity	1.33e-06	2.6e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—obesity	1.25e-06	2.44e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CD—obesity	1.24e-06	2.41e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—obesity	1.23e-06	2.39e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—obesity	1.22e-06	2.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—obesity	1.18e-06	2.3e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—obesity	1.17e-06	2.28e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3R1—obesity	1.17e-06	2.28e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—obesity	1.16e-06	2.26e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—obesity	1.16e-06	2.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—obesity	1.09e-06	2.13e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CB—obesity	1.08e-06	2.1e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—obesity	1.07e-06	2.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—obesity	1.01e-06	1.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—obesity	1e-06	1.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—obesity	9.97e-07	1.94e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—obesity	8.94e-07	1.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—obesity	8.22e-07	1.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—obesity	8.15e-07	1.59e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—obesity	6.58e-07	1.28e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—obesity	5.37e-07	1.05e-05	CbGpPWpGaD
